Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.

Linger RM, DeRyckere D, Brandão L, Sawczyn KK, Jacobsen KM, Liang X, Keating AK, Graham DK

Open source

DOI
10.1182/blood-2009-03-209247
Published
2009 Sep 24
Container
Blood
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/blood-2009-03-209247,
  title = {Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.},
  author = {Linger RM and DeRyckere D and Brandão L and Sawczyn KK and Jacobsen KM and Liang X and Keating AK and Graham DK},
  year = {2009},
  journal = {Blood},
  doi = {10.1182/blood-2009-03-209247},
  url = {https://doi.org/10.1182/blood-2009-03-209247}
}

RIS

TY  - JOUR
TI  - Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.
AU  - Linger RM
AU  - DeRyckere D
AU  - Brandão L
AU  - Sawczyn KK
AU  - Jacobsen KM
AU  - Liang X
AU  - Keating AK
AU  - Graham DK
PY  - 2009
JO  - Blood
DO  - 10.1182/blood-2009-03-209247
UR  - https://doi.org/10.1182/blood-2009-03-209247
ER  - 

APA

RM, L., D, D., L, B., KK, S., KM, J., X, L., AK, K., & DK, G. (2009). Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.. Blood. https://doi.org/10.1182/blood-2009-03-209247

Source records